July 30, 2019

White House Announces Efforts to Promote Greater Price Transparency For Prescription Drugs

On June 25, the White House announced an initiative to encourage greater transparency in drug pricing. President Trump signed an Executive Order on June 25, entitled “Improving Price and Quality Transparency in American Healthcare to Put Patients First.” The purpose of the order is to direct federal agencies to issue regulations to improve the transparency of health care prices and quality in order to create a more competitive marketplace and provide consumers with the information they need to make informed purchasing decisions.  More specifically, the executive order: Directs the Secretary of Health and Human Services (HHS) to issue regulations within 60 days that would require hospitals to publicly post standard charge information, including information based on negotiated rates, in an […]
April 30, 2019

HHS Announces Extended Comment Period for Healthcare Interoperability Proposed Rules, Releases New HIPAA FAQs

The U.S. Department of Health and Human Services (HHS) announced that it would extend until June 3 the comment periods for CMS and the Office of the National Coordinator for Health Information Technology (ONC) proposed interoperability and information blocking rules. CMS also announced that as a result of public comments, it will adjust the effective dates of its policies to allow for adequate implementation timelines as appropriate. In addition, HHS released a set of frequently asked questions (FAQs) from the Office for Civil Rights (OCR), addressing HIPAA’s right of access as related to apps designated by individual patients and application programming interfaces (APIs) used by a health care provider’s electronic health record (EHR) system. The FAQs clarify, among other things, that once protected health […]